Condorcet Global Opportunity Fund’s Allergan Inc AGN Stock Holding History

Condorcet Global Opportunity Fund’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	$19.2M	Buy	+90,429	New	+$18M	7.95%	4

Other funds holding AGN

PSCM

Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return

LTI

Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Condorcet Global Opportunity Fund's AGN Position: Q4 2014 in Review

Condorcet Global Opportunity Fund opened a new position in Allergan Inc (AGN) in Q4 2014: 90,429 shares worth $19.2M. The stake represents 7.95% of the portfolio and ranks #4 among its holdings.

819 funds tracked by Wall St. Rank hold AGN as of Q4 2014.

Condorcet Global Opportunity Fund held 90,429 shares of Allergan Inc worth $19.2M as of Q4 2014.
Allergan Inc was a new Condorcet Global Opportunity Fund position in Q4 2014.
Allergan Inc made up 7.95% of Condorcet Global Opportunity Fund's portfolio in Q4 2014, its #4 holding.
819 funds tracked by Wall St. Rank held Allergan Inc as of Q4 2014.

Based on Condorcet Global Opportunity Fund's 13F filing for Q4 2014, filed 17 Feb 2015.